Suppr超能文献

选定配方变量对包埋酶的聚丙烯酸树脂S100微球制备的影响。

Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.

作者信息

Rawat Manju, Saraf Shailendra, Saraf Swarnlata

机构信息

Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur, C.G.-492010, India.

出版信息

AAPS PharmSciTech. 2007 Dec 28;8(4):E116. doi: 10.1208/pt0804116.

Abstract

The aim of this work is to study the influence of formulation parameters in the preparation of sustained release enzyme-loaded Eudragit S100 microspheres by emulsion solvent diffusion technique. A 3(2) full factorial experiment was designed to study the effects of the amount of solvent (dichloromethane) and stabilizers (Tween 20, 40, or 80) on the drug content and microsphere size. The results of analysis of variance test for both effects indicated that the test is significant. The effect of amount of stabilizer was found to be higher on both responses (SS(Y1) = 45.60; SS(Y2) = 737.93), whereas solvent concentration comparatively produced significant effect on the size of microspheres (SS(Y1) = 0.81; SS(Y2) = 358.83). Scanning electron microscopy of microspheres with maximum drug content (2.5 mL dichloromethane and 0.1 mL Tween 80) demonstrated smooth surface spherical particles with mean diameter of 56.83 +/- 2.88 microm. The effect of formulation variables on the integrity of enzyme was confirmed by in vitro proteolytic activity. The enteric nature of microspheres was evaluated and results demonstrated ~6% to 7% release of enzyme in acidic medium. The release of enzyme from microspheres followed Higuchi kinetics. In phosphate buffer, microspheres showed an initial burst release of 20.34% +/- 2.35% in 1 hour with additional 58.79% +/- 4.32% release in the next 5 hours. Three dimensional response graphs were presented to visualize the effect of independent variables on the chosen response. Thus, Eudragit S100 microspheres can be successfully prepared for oral delivery of enzymes with desirable characters in terms of maximum loading and diffusion release pattern.

摘要

本研究旨在通过乳液溶剂扩散技术,研究制剂参数对制备载酶缓释型Eudragit S100微球的影响。设计了一个3(2)全因子实验,以研究溶剂(二氯甲烷)和稳定剂(吐温20、40或80)的用量对药物含量和微球尺寸的影响。对这两种效应的方差分析结果表明该测试具有显著性。结果发现,稳定剂用量对两种响应的影响更大(SS(Y1)=45.60;SS(Y2)=737.93),而溶剂浓度对微球尺寸的影响相对显著(SS(Y1)=0.81;SS(Y2)=358.83)。对药物含量最高的微球(2.5 mL二氯甲烷和0.1 mL吐温80)进行扫描电子显微镜观察,结果显示表面光滑的球形颗粒,平均直径为56.83±2.88微米。通过体外蛋白水解活性证实了制剂变量对酶完整性的影响。对微球的肠溶性质进行了评估,结果表明在酸性介质中酶的释放率约为6%至7%。微球中酶的释放符合Higuchi动力学。在磷酸盐缓冲液中,微球在1小时内初始突释率为20.34%±2.35%,在接下来的5小时内又释放了58.79%±4.32%。绘制了三维响应图,以直观显示自变量对所选响应的影响。因此,就最大载药量和扩散释放模式而言,Eudragit S100微球可成功制备用于口服给药的具有理想特性的酶。

相似文献

引用本文的文献

3
Analytical techniques for serratiopeptidase: A review.沙雷氏菌蛋白酶的分析技术:综述
J Pharm Anal. 2017 Aug;7(4):203-207. doi: 10.1016/j.jpha.2017.03.005. Epub 2017 Mar 22.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验